Journal
DIGESTIVE AND LIVER DISEASE
Volume 49, Issue 6, Pages 604-617Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.dld.2017.01.161
Keywords
Corticosteroids; Crohn's disease; Guidelines; IBD; Immunosuppressors; Ulcerative colitis
Categories
Funding
- Abbvie
- Ferring
- Hospira
- Janssen
- MSD
- Mundipharma
- Takeda
Ask authors/readers for more resources
The two main forms of intestinal bowel disease, namely ulcerative colitis and Crohn's disease, are not curable but can be controlled by various medical therapies. The Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) has prepared clinical practice guidelines to help physicians prescribe corticosteroids and immunosuppressive drugs for these patients. The guidelines consider therapies that induce remission in patients with active disease as well as treatment regimens that maintain remission. These guidelines complement already existing guidelines from IG-IBD on the use of biological drugs in patients with inflammatory bowel diseases. (C) 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available